Botox injection shows promise for restless legs relief
NCT ID NCT00949806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether botulinum toxin type A (like Botox) can ease symptoms of restless legs syndrome (RLS) in 27 adults who did not get enough relief from standard treatments. Participants received one injection, and researchers checked if leg discomfort and urge to move improved by at least half over 24 weeks. The goal is to offer a new option for people with severe RLS.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEGS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux
Pessac, 33600, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Large survey aims to uncover hidden pain in restless legs syndrome
- Spine injection may quiet restless legs, small study hints
- New device offers Drug-Free hope for restless legs sufferers
- New drug candidate aims to calm restless legs when current meds backfire
- Could needling zap restless legs away?
- Could a drug for addiction help restless legs sufferers?